دورية أكاديمية
P1240: ANTI-PD-1-ANTIBODY (TISLELIZUMAB) COMBINED WITH DEACETYLASE INHIBITOR (CHIDAMIDE), LENALIDOMIDE AND ETOPOSIDE FOR THE TREATMENT OF REFRACTORY/RELAPSED EXTRANODAL NATURAL KILLER/T CELL LYMPHOMA, NASAL
| العنوان: | P1240: ANTI-PD-1-ANTIBODY (TISLELIZUMAB) COMBINED WITH DEACETYLASE INHIBITOR (CHIDAMIDE), LENALIDOMIDE AND ETOPOSIDE FOR THE TREATMENT OF REFRACTORY/RELAPSED EXTRANODAL NATURAL KILLER/T CELL LYMPHOMA, NASAL |
|---|---|
| المؤلفون: | L. Zhang, X. Liu, X. Wang, Y. Chang, X. Fu, X. Li, L. Li, X. Zhang, J. Yan, F. Nan, L. Zhu, Z. Sun, H. Yu, S. Guo, W. Sang, L. Wang, M. Zhang |
| المصدر: | HemaSphere, Vol 6, Pp 1125-1126 (2022) |
| بيانات النشر: | Wiley, 2022. |
| سنة النشر: | 2022 |
| المجموعة: | LCC:Diseases of the blood and blood-forming organs |
| مصطلحات موضوعية: | Diseases of the blood and blood-forming organs, RC633-647.5 |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 2572-9241 00008478 |
| Relation: | http://journals.lww.com/10.1097/01.HS9.0000847824.69595.f0; https://doaj.org/toc/2572-9241 |
| DOI: | 10.1097/01.HS9.0000847824.69595.f0 |
| URL الوصول: | https://doaj.org/article/e574601b354c425c8a7ed8001671b657 |
| رقم الأكسشن: | edsdoj.574601b354c425c8a7ed8001671b657 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 25729241 00008478 |
|---|---|
| DOI: | 10.1097/01.HS9.0000847824.69595.f0 |